Robert W. Baird lowered shares of Geron (NASDAQ:GERN – Free Report) from an outperform rating to a neutral rating in a report published on Tuesday, MarketBeat Ratings reports. The firm currently has $4.50 price objective on the biopharmaceutical company’s stock. Several other brokerages also recently commented on GERN. Needham & Company LLC restated a buy […]
TD Cowen started coverage on shares of Geron (NASDAQ:GERN – Free Report) in a research report sent to investors on Monday morning, MarketBeat reports. The firm issued a buy rating and a $10.00 price objective on the biopharmaceutical company’s stock. Several other equities research analysts have also commented on the stock. Wedbush reaffirmed an outperform […]
Geron (NASDAQ:GERN – Get Free Report) is set to post its quarterly earnings results before the market opens on Thursday, May 2nd. Analysts expect Geron to post earnings of ($0.10) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link. Geron (NASDAQ:GERN – Get […]
Geron Co. (NASDAQ:GERN – Get Free Report)’s share price reached a new 52-week high during trading on Monday . The company traded as high as $4.05 and last traded at $4.01, with a volume of 6313886 shares traded. The stock had previously closed at $3.79. Analyst Upgrades and Downgrades A number of equities analysts recently […]
Arizona State Retirement System decreased its position in Geron Co. (NASDAQ:GERN – Free Report) by 15.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 109,729 shares of the biopharmaceutical company’s stock after selling 20,647 shares during the quarter. Arizona State Retirement System’s holdings in […]
Geron (NASDAQ:GERN – Get Free Report)‘s stock had its “outperform” rating reiterated by Wedbush in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $6.00 price objective on the biopharmaceutical company’s stock. Wedbush’s target price indicates a potential upside of 71.92% from the company’s previous close. Other equities analysts have […]
Shares of Geron Co. (NASDAQ:GERN – Get Free Report) shot up 2.2% during mid-day trading on Tuesday . The company traded as high as $3.24 and last traded at $3.24. 1,045,219 shares changed hands during mid-day trading, a decline of 91% from the average session volume of 11,093,395 shares. The stock had previously closed at […]
Twin Peaks Wealth Advisors LLC bought a new stake in Geron Co. (NASDAQ:GERN – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 27,637 shares of the biopharmaceutical company’s stock, valued at approximately $58,000. Other large investors have also modified […]
Twin Peaks Wealth Advisors LLC purchased a new position in shares of Geron Co. (NASDAQ:GERN – Free Report) during the fourth quarter, HoldingsChannel reports. The institutional investor purchased 27,637 shares of the biopharmaceutical company’s stock, valued at approximately $58,000. A number of other large investors also recently made changes to their positions in GERN. Sei […]
Geron Co. (NASDAQ:GERN – Get Free Report) was the target of some unusual options trading activity on Monday. Stock investors acquired 35,399 put options on the stock. This is an increase of approximately 1,665% compared to the average volume of 2,006 put options. Geron Price Performance Shares of GERN stock traded down $0.18 during mid-day […]